GCT is thrilled to announce the successful completion of enrollment for a Respiratory Pediatric Phase IV Clinical Trial. Notably, we concluded the recruitment phase two months ahead of schedule, a testament to the dedication of our colleagues in Bulgaria and Romania, as well as our motivated Investigators and site staff.

This study aims to assess the efficacy and safety of an alcohol-free spray and lozenges in pediatric patients (6-12 years) with sore throat. We are proud to collaborate on this endeavor with our longstanding partner, ZAK-Pharma Dienstleistung Ges.m.b.H.